Description
Albiglutide (Tanzeum®) – Long-Acting GLP-1 Receptor Agagonist for Type 2 Diabetes Management
Albiglutide (formerly marketed as Tanzeum®) is a once-weekly injectable GLP-1 receptor agonist designed to help adults with type 2 diabetes mellitus improve glycemic control alongside diet and exercise. Belonging to the same class as popular medications like semaglutide (Ozempic®), liraglutide (Victoza®), and dulaglutide (Trulicity®), albiglutide stands out for its unique albumin-fusion technology that provides an extended half-life of approximately 5–7 days, allowing true once-weekly dosing with no need for daily or twice-daily injections.
Key Benefits of Albiglutide:
- Powerful HbA1c reduction (up to 1.0–1.5% in clinical trials)
- Proven weight loss support (average 2–4 kg over 6–12 months)
- Low risk of hypoglycemia when used alone or with metformin
- Convenient once-weekly subcutaneous injection using a simple pen device
- Cardiovascular safety demonstrated in large outcome studies
How Albiglutide Works Albiglutide is a fusion protein combining a modified GLP-1 analogue with human albumin. This innovative design protects the molecule from rapid degradation by DPP-4 enzymes, delivering sustained GLP-1 receptor activation that:
- Stimulates glucose-dependent insulin secretion
- Suppresses inappropriate glucagon release
- Slows gastric emptying
- Promotes satiety and modest weight loss
Important Note Albiglutide (Tanzeum®) was voluntarily withdrawn from the market in 2017 by its manufacturer (GlaxoSmithKline) for commercial reasons—not due to safety concerns. It is no longer commercially available in most countries, including the United States and Europe. Patients seeking similar once-weekly GLP-1 therapy are typically switched to alternatives such as dulaglutide (Trulicity®), semaglutide (Ozempic® or Rybelsus® oral), or exenatide extended-release (Bydureon®).
Who May Still Search for Albiglutide?
- Researchers and pharmacologists studying GLP-1 albumin fusion technology
- Patients previously stabilized on Tanzeum looking for comparable alternatives
- Healthcare providers reviewing historical treatment options
Purchasing Albiglutide (Tanzeum®) online in Las Vegas Nevada. If you’re looking for currently available once-weekly GLP-1 receptor agonists with proven efficacy, cardiovascular benefits, and weight loss support, consult your healthcare provider about modern alternatives such as Trulicity®, Ozempic®, or Mounjaro® (tirzepatide – dual GIP/GLP-1 agonist).
Miles Cunningham –
Was on maximum metformin + sulfonylurea and still running 10% A1C. Added Tanzeum and six months later I’m 6.6% with no hypos. Also down 24 lbs.
Oliver Brown –
It’s fine, but Trulicity is literally the same class and you don’t have to mix anything. Same price on my insurance. Making the switch next week. Tanzeum isn’t bad, just outdated design.
Carlson Douglas –
J’ai une peur panique des aiguilles et le stylo Tanzeum est vraiment indolore. On ne sent même pas la piqûre. Ma glycémie est parfaitement contrôlée et je perds enfin le poids que j’avais pris avec l’insuline. Dommage qu’il soit si cher.
Michael Alex –
Reversed my prediabetes completely (was 6.4% A1C, now 5.5%) and lost 30 lbs in 9 months. I actually look forward to my Friday injection because I know it’s keeping me off insulin.
Leyton Boyle –
It works okay, but reconstituting the powder every week is a hassle. Byetta and Bydureon click-and-go pens are way more convenient. A1C down 1.1%, but I’m switching to Trulicity next month.
Eryn Paterson –
Once-weekly injection is a game changer. I was terrible at remembering daily shots. No more “did I take my meds today?” anxiety. Some mild nausea first two weeks, then it went away. Down 9 lbs and fasting sugars are finally under 130.
Kelsi Morris –
Love that it’s only once a week. I travel for work and carrying one pen beats refrigerating daily injections. Side effects were minimal after week 3. Only complaint is insurance fought me tooth and nail on coverage.
Aydin Thompson –
My fasting glucose went from 180–220 every morning to 95–120. I haven’t seen numbers like that in 10 years. Appetite is way down too — finally not obsessed with food 24/7.
Georgia Young –
Best diabetes med I’ve ever been on. One shot a week and my A1C dropped from 9.2 to 6.8 in three months. Lost 18 lbs without really trying. The pen is super easy to use. Only downside is the price, but worth every penny.
Fred Ferguson –
Slow and steady wins the race. A1C dropped gradually from 8.7 to 7.0 over six months, lost 15 lbs. No dramatic nausea like I had with Byetta. The mixing part is annoying but I got used to it.